Trial Information
Current as of August 20, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Non-invasive brain stimulation (NIBS) has attracted considerable interest in the cognitive neuroscience community, providing an important basic research tool to study brain function, with emerging clinical applications to enhance function in individuals with neurological disorders.
The investigators have developed a radically new NIBS approach, one in which subthreshold modulation of neural excitability is brought about via oscillating magnetic fields at kilohertz (kHZ) frequencies. This system, referred to kTMP (kHz Transcranial Magnetic Perturbation) significantly increases the range of ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18-75
- Exclusion Criteria:
- • serious medical condition
- • had a seizure of any sort
- • epilepsy or experienced seizures
- • neurological disorder
- • head injury
- • stroke
- • had any form of brain surgery
- • history of migraine
- • metal implants in your head, excluding the mouth
- • pacemaker
- • implanted medical devices of any sort
- • pregnant
- • hearing loss or hearing impairments
- • jet lag
- • stress
- • substance abuse
- • highly stressful event over the past 24 hours
- • broken or abnormal skin on your scalp
About Magnetic Tides
Magnetic Tides is a pioneering clinical trial sponsor dedicated to advancing innovative therapies through rigorous research and development. With a focus on harnessing the potential of magnetic resonance technologies, we strive to enhance treatment outcomes across a variety of medical conditions. Our commitment to scientific excellence and patient safety drives our collaborative approach, working closely with healthcare professionals and research institutions to ensure the highest standards in clinical trial design and execution. At Magnetic Tides, we are devoted to translating groundbreaking discoveries into effective therapies that improve patient lives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
El Cerrito, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported